The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor

被引:93
作者
Bovenschen, N
Rijken, DC
Havekes, LM
Van Vlijmen, BJM
Mertens, K
机构
[1] Sanquin Res CLB, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands
[2] TNO Prevent & Hlth, Gaubius Lab, Leiden, Netherlands
[3] Erasmus MC, Dept Haematol, Rotterdam, Netherlands
[4] LUMC, Dept Cardiol, Leiden, Netherlands
[5] LUMC, Dept Internal Med, Leiden, Netherlands
[6] LUMC, Dept Hematol, Leiden, Netherlands
[7] Univ Utrecht, UIPS, Utrecht, Netherlands
关键词
asialoglycoprotein receptor; clearance; factor VIII; mice; oligosaccharides; surface plasmon resonance;
D O I
10.1111/j.1538-7836.2005.01389.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Coagulation factor VIII (FVIII) is a heavily glycosylated heterodimeric plasma protein that consists of a heavy (domains A1-A2-B) and light chain (domains A3-C1-C2). It has been well established that the clearance of FVIII from the circulation involves mechanisms that are sensitive to the low-density lipoprotein receptor (LDLR) family antagonist receptor-associated protein (RAP), including LDLR-related protein. Because FVIII clearance in the presence of a bolus injection of RAP still occurs fairly efficient, also RAP-independent mechanisms are likely to be involved. Objectives: In the present study, we investigated the interaction of FVIII with the endocytic lectin asialoglycoprotein receptor (ASGPR) and the physiological relevance thereof. Methods and results: Surface plasmon resonance studies demonstrated that FVIII dose-dependently bound to ASGPR with high affinity (K-d approximate to 2 nm). FVIII subunits were different in that only the heavy chain displayed high-affinity binding to ASGPR. Studies employing a FVIII variant that lacks the B domain revealed that FVIII-ASGPR complex assembly is driven by structure elements within the B domain of the heavy chain. The FVIII heavy chain-ASGPR interaction required calcium ions and was inhibited by soluble D-galactose. Furthermore, deglycosylation of the FVIII heavy chain by endoglycosidase F completely abrogated the interaction with ASGPR. In clearance experiments in mice, the FVIII mean residence time was prolonged by the ASGPR-antagonist asialo-orosomucoid (ASOR). Conclusions: We conclude that asparagine-linked oligosaccharide structures of the FVIII B domain recognize the carbohydrate recognition
引用
收藏
页码:1257 / 1265
页数:9
相关论文
共 35 条
[1]   ISOLATION AND CHARACTERIZATION OF HUMAN FACTOR-VIII - MOLECULAR-FORMS IN COMMERCIAL FACTOR-VIII CONCENTRATE, CRYOPRECIPITATE, AND PLASMA [J].
ANDERSSON, LO ;
FORSMAN, N ;
HUANG, K ;
LARSEN, K ;
LUNDIN, A ;
PAVLU, B ;
SANDBERG, H ;
SEWERIN, K ;
SMART, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (09) :2979-2983
[2]   CARBOHYDRATE-SPECIFIC RECEPTORS OF THE LIVER [J].
ASHWELL, G ;
HARFORD, J .
ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 :531-554
[3]  
BAENZIGER JU, 1980, J BIOL CHEM, V255, P4607
[4]   Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose-independent manner [J].
Bennatt, DJ ;
Ling, YY ;
McAbee, DD .
BIOCHEMISTRY, 1997, 36 (27) :8367-8376
[5]   The oligomerization domain of the asialoglycoprotein receptor preferentially forms 2:2 heterotetramers in vitro [J].
Bider, MD ;
Wahlberg, JM ;
Kammerer, RA ;
Spiess, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) :31996-32001
[6]   Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII [J].
Bovenschen, N ;
Boertjes, RC ;
van Stempvoort, G ;
Voorberg, J ;
Lenting, PJ ;
Meijer, AB ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) :9370-9377
[7]   Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency [J].
Bovenschen, N ;
Herz, J ;
Grimbergen, JM ;
Lenting, PJ ;
Havekes, LM ;
Mertens, K ;
van Viijmen, BJM .
BLOOD, 2003, 101 (10) :3933-3939
[8]   PURIFIED HUMAN FACTOR-VIII PROCOAGULANT PROTEIN - COMPARATIVE HEMOSTATIC RESPONSE AFTER INFUSIONS INTO HEMOPHILIC AND VONWILLEBRAND DISEASE DOGS [J].
BRINKHOUS, KM ;
SANDBERG, H ;
GARRIS, JB ;
MATTSSON, C ;
PALM, M ;
GRIGGS, T ;
READ, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8752-8756
[9]  
BU G, 2001, INT REV CYTOL, V209, P76
[10]   Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands [J].
Ellies, LG ;
Ditto, D ;
Levy, GG ;
Wahrenbrock, M ;
Ginsburg, D ;
Varki, A ;
Le, DT ;
Marth, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :10042-10047